ArticleMicroorganisms2021
Changes in Invasive Pneumococcal Disease Caused by
Open access · goldAbstract read
In one paragraph
Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.
- Complicated pneumococcal pneumonia in the era of higher-valent pneumococcal conjugate vaccines: a systematic literature review and meta-analysis, 2001-2022.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Pooled it
- Transcriptomic analysis ofMicrobial genomics · 2025Article
- Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.The Lancet. Infectious diseases · 2025Article
- Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.The Lancet. Infectious diseases · 2025Article
- Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project.The Journal of infection · 2025Article
- Outbreak of Serotype 1 Invasive Pneumococcal Disease, Kibera Urban Informal Settlement, Nairobi, Kenya, 2023.Emerging infectious diseases · 2025Article
- Pneumococcal carriage in a large Sicilian sample population: impact on the current epidemiological scenario and implications for future vaccination strategies.Frontiers in cellular and infection microbiology · 2024Observational
- Linkage between Airborne Particulate Matter and Viral Pandemic COVID-19 in Bucharest.Microorganisms · 2023Article
- Serotype 1 pneumococcus: epidemiology, genomics, and disease mechanisms.Trends in microbiology · 2022Review
- Age-Dependent Serotype-Associated Case-Fatality Rate in Invasive Pneumococcal Disease in the Autonomous Community of Madrid between 2007 and 2020.Microorganisms · 2021Article
- Observational
- Editorial for the Special Issue: Bacterial Meningitis-Epidemiology and Vaccination.Microorganisms · 2021Article
- Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project.Microorganisms · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
62 authors at 20 institutions in 38 countries.
Julia C BennettJohns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.ORCID 0000-0003-2559-2922
Marissa K HetrichJohns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Maria Garcia QuesadaJohns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.ORCID 0000-0002-0206-7597
Jenna N SinkevitchJohns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Maria Deloria KnollJohns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.ORCID 0000-0001-9041-2671
Daniel R FeikinIndependent Consultant, 1296 Coppet, Switzerland.
Scott L ZegerJohns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Eunice W KaguciaKEMRI-Wellcome Trust Research Programme, Epidemiology and Demography Department, Centre for Geographic Medicine-Coast, P.O. Box 230-80108, Kilifi, Kenya.
Adam L CohenWorld Health Organization, 1202 Geneva, Switzerland.
Krow AmpofoDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA.
Maria-Cristina C BrandileoneNational Laboratory for Meningitis and Pneumococcal Infections, Center of Bacteriology, Institute Adolfo Lutz (IAL), São Paulo 01246-902, Brazil.ORCID 0000-0002-7254-9102
Dana BrudenArctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK 99508, USA.
Romina CamilliDepartment of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità, ISS), 00161 Rome, Italy.
Jesús CastillaCIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.ORCID 0000-0002-6396-7265
Guanhao ChanSingapore Ministry of Health, Communicable Diseases Division, Singapore 308442, Singapore.
Heather CookCentre for Disease Control, Department of Health and Community Services, Darwin, NT 8000, Australia.
Jennifer E CornickInstitute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool CH64 7TE, UK.
Ron DaganFaculty of Health Sciences, Ben-Gurion University of the Negev, 8410501 Beer-Sheva, Israel.
Tine DalbyBacteria, Parasites and Fungi, Statens Serum Institut, DK-2300 Copenhagen, Denmark.ORCID 0000-0003-4774-7091
Kostas DanisSanté Publique France, the French National Public Health Agency, Saint Maurice CEDEX, 94415 Paris, France.
Sara de MiguelEpidemiology Department, Dirección General de Salud Pública, 28009 Madrid, Spain.
Philippe De WalsDepartment of Social and Preventive Medicine, Laval University, Québec, QC G1V 0A6, Canada.
Stefanie DesmetDepartment of Microbiology, Immunology and Transplantation, KU Leuven, BE-3000 Leuven, Belgium.
Theano GeorgakopoulouNational Public Health Organisation, 15123 Athens, Greece.
Charlotte GilkisonEpidemiology Team, Institute of Environmental Science and Research, Porirua, 5240 Wellington, New Zealand.
Marta Grgic-VitekCommunicable Diseases Centre, National Institute of Public Health, 1000 Ljubljana, Slovenia.
Laura L HammittJohns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Markus HiltySwiss National Reference Centre for Invasive Pneumococci, Institute for Infectious Diseases, University of Bern, 3012 Bern, Switzerland.
Pak-Leung HoDepartment of Microbiology and Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong, China.ORCID 0000-0002-8811-1308
Sanjay JayasingheNational Centre for Immunisation Research and Surveillance and Discipline of Child and Adolescent Health, Children's Hospital Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Westmead, NSW 2145, Australia.
James D KellnerDepartment of Pediatrics, University of Calgary, and Alberta Health Services, Calgary, AB T3B 6A8, Canada.
Jackie KleynhansCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, 2192 Johannesburg, South Africa.ORCID 0000-0001-7081-6273
Mirjam J KnolNational Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands.
Jana KozakovaNational Institute of Public Health (NIPH), 100 42, Praha Czech Republic.
Karl G KristinssonDepartment of Clinical Microbiology, Landspitali-The National University Hospital, Hringbraut, 101 Reykjavik, Iceland.
Shamez N LadhaniImmunisation and Countermeasures Division, Public Health England, London NW9 5EQ, UK.
Laura MacDonaldPublic Health Scotland, Glasgow G2 6QE, UK.ORCID 0000-0002-0972-6233
Grant A MackenzieFaculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel St, London, WC1E 7HT, UK.
Lucia Mad'arováNational Reference Centre for Pneumococcal and Haemophilus Diseases, Regional Authority of Public Health, 975 56 Banská Bystrica, Slovakia.ORCID 0000-0001-8546-395X
Allison McGeerToronto Invasive Bacterial Diseases Network, Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Jolita MereckieneHSE Health Protection Surveillance Centre, Mountjoy, Dublin D01 A4A3, Ireland.
Eva MorfeldtDepartment of Microbiology, Public Health Agency of Sweden, 171 82 Solna, Sweden.
Tuya MungunNational Center of Communicable Diseases (NCCD), Ministry of Health, Bayanzurkh District, Ulaanbaatar 13336, Mongolia.
Carmen Muñoz-AlmagroCIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.ORCID 0000-0001-5586-404X
J Pekka NuortiDepartment of Health Security, Finnish Institute for Health and Welfare, 00271 Helsinki, Finland.
Metka ParagiCentre for Medical Microbiology, National Laboratory of Health, Environment and Food, 2000 Maribor, Slovenia.
Tamara PilishviliNational Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Rodrigo PuentesInstituto de Salud Pública de Chile, 7780050 Santiago, Santiago Metropolitan, Chile.ORCID 0000-0001-8607-2467
Samir K SahaChild Health Research Foundation, Dhaka 1207, Bangladesh.
Aalisha Sahu KhanMinistry of Health and Medical Services, Suva, Fiji.
Larisa SavrasovaCentre for Disease Prevention and Control of Latvia, 1005 Riga, Latvia.
J Anthony ScottKEMRI-Wellcome Trust Research Programme, Epidemiology and Demography Department, Centre for Geographic Medicine-Coast, P.O. Box 230-80108, Kilifi, Kenya.
Anna SkoczyńskaNational Reference Centre for Bacterial Meningitis, National Medicines Institute, 00-725 Warsaw, Poland.ORCID 0000-0002-2247-830X
Shigeru SugaInfectious Disease Center and Department of Clinical Research, National Hospital Organization Mie Hospital, Tsu, Mie 514-0125, Japan.
Mark van der LindenNational Reference Center for Streptococci, Department of Medical Microbiology, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Jennifer R VeraniNational Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Anne von GottbergCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, 2192 Johannesburg, South Africa.ORCID 0000-0002-0243-7455
Brita A WinjeDepartment of Infection Control and Vaccine, Norwegian Institute of Public Health, 0456 Oslo, Norway.
Inci YildirimDepartment of Pediatrics, Yale New Haven Children's Hospital, New Haven, CT 06504, USA.ORCID 0000-0002-8631-0020
Khalid ZeroualiBacteriology-Virology and Hospital Hygiene Laboratory, Ibn Rochd University Hospital Centre, Casablanca 20250, Morocco.
Kyla HayfordJohns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.ORCID 0000-0002-9872-2313
The Pserenade Team
Johns Hopkins University · USCenters for Disease Control and Prevention · USKenya Medical Research Institute · KENational Health Laboratory Service · ZAAlberta Health Services · CABen-Gurion University of the Negev · ILCentre Hospitalier Universitaire Ibn Rochd · MAChild Health Research Foundation · BDGovernment of Western Australia Department of Health · AUHealth Protection Surveillance Centre · IEHospital Sant Joan de Déu Barcelona · ESInstituto Adolfo Lutz · BRInstituto de Salud Pública de Chile · CLInstituto de Salud Pública de Navarra · ESIstituto Superiore di Sanità · ITKU Leuven · BEMinistry of Health · SGMinistry Of Health · FJNarodowy Instytut Leków · PLNational Center for Communicable Diseases · MN
Funding
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9MBill and Melinda Gates Foundation INV-010429 / OPP1189065NCATS NIH HHS UL1 TR001863World Health Organization 001
Abstract
PubMed holds no abstract for this paper.
Indexed as
invasive pneumococcal diseasepneumococcal conjugate vaccinesserotypesvaccine impact
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.